The European Medicines Agency (EMA) is an agency of the European Union (EU) in charge of the evaluation and supervision of pharmaceutical products. Prior...
43 KB (3,701 words) - 20:03, 12 September 2024
ensuring that medicines and medical devices work and are acceptably safe. The MHRA was formed in 2003 with the merger of the Medicines Control Agency (MCA) and...
26 KB (2,421 words) - 18:24, 19 November 2024
similar model to that of the European Medicines Agency, it is intended to have a wide scope covering medicines, traditional medicine, and medical devices. The...
20 KB (1,874 words) - 10:53, 17 November 2024
copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Dapagliflozin Viatris EPAR". European Medicines Agency. 4...
53 KB (4,975 words) - 03:43, 30 September 2024
Biosimilar (section European Union)
their lifecycle. Drug-related authorities such as the European Medicines Agency (EMA) of the European Union, the United States Food and Drug Administration...
97 KB (6,512 words) - 06:28, 8 October 2024
European Medicines Agency (EMA). 29 January 2020. Archived from the original on 14 August 2020. Retrieved 26 September 2020. "Wegovy EPAR". European Medicines...
74 KB (6,327 words) - 20:35, 24 November 2024
responsible for the regulatory activity of pharmaceuticals in Italy. European Medicines Agency Istituto Superiore di Sanità Official website v t e v t e...
464 bytes (37 words) - 18:24, 13 May 2024
loss in November 2023. In November 2023, the UK Medicines and Healthcare products Regulatory Agency revised the indication for tirzepatide to include...
44 KB (3,499 words) - 17:04, 24 November 2024
Denosumab (section European Union)
March 2024". European Medicines Agency (Press release). 22 March 2024. Retrieved 13 June 2024. "Wyost EPAR". European Medicines Agency. 21 March 2024...
29 KB (2,520 words) - 06:36, 16 November 2024
N-Nitrosodimethylamine (section European Union)
copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Nitrosamine impurities". European Medicines Agency (EMA)...
25 KB (2,372 words) - 22:10, 6 November 2024
code itself is issued by the Medicines and Healthcare products Regulatory Agency in the UK and the European Medicines Agency. "Martin Lewis: A drugs bust...
2 KB (113 words) - 01:12, 28 October 2024
EPAR". European Medicines Agency. 25 July 2024. Retrieved 29 July 2024. Text was copied from this source which is copyright European Medicines Agency. Reproduction...
38 KB (3,075 words) - 05:52, 21 October 2024
copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Synflorix EPAR". European Medicines Agency (EMA). 17...
52 KB (4,469 words) - 05:30, 5 September 2024
the European Medicines Agency (EMEA); DH; Food Standards Agency (FSA); and consumers. Residues – the surveillance for residues of veterinary medicines and...
5 KB (559 words) - 04:00, 25 April 2022
Mresvia was approved for medical use in the European Union in August 2024. "Arexvy EPAR". European Medicines Agency (EMA). 16 June 2023. Archived from the...
54 KB (4,327 words) - 07:31, 15 November 2024
and methods of analysis for medicines. These standards apply to medicines for both human and veterinary use. The European Pharmacopoeia has a legally...
11 KB (1,319 words) - 20:02, 7 November 2024
Director of the European Medicines Agency (EMA) since November 2020. She is also the chairperson at the International Coalition of Medicines Regulatory Authorities...
6 KB (466 words) - 18:07, 13 December 2023
"Fluenz EPAR". European Medicines Agency (EMA). 17 December 2013. Retrieved 6 August 2020. "Fluenz Tetra EPAR". European Medicines Agency (EMA). 17 December...
22 KB (2,049 words) - 05:50, 21 October 2024
European Medicines Agency in the European Union. In January 2018, the Committee for Medicinal Products for Human Use of the European Medicines Agency...
17 KB (1,509 words) - 01:34, 14 June 2024
Lecanemab (section European Union)
European Medicines Agency (EMA). 14 November 2024. Retrieved 14 November 2024. Text was copied from this source which is copyright European Medicines...
29 KB (2,556 words) - 20:50, 14 November 2024
Ellipta EPAR". European Medicines Agency (EMA). 10 December 2013. Retrieved 23 March 2021. "Revinty Ellipta". European Medicines Agency (EMA). 2 May 2014...
9 KB (645 words) - 00:39, 2 October 2024
copyright European Medicines Agency. Reproduction is authorized provided the source is acknowledged. "Kesimpta EPAR". European Medicines Agency (EMA). 25...
28 KB (2,001 words) - 01:03, 31 August 2024
European Medicines Agency. 14 December 2021. Retrieved 20 April 2022. Text was copied from this source which is copyright European Medicines Agency....
15 KB (1,080 words) - 05:16, 15 October 2024
H-W-2495". European Medicines Agency (EMA). Archived from the original on 2 October 2018. Retrieved 28 June 2018. "European Medicines Agency recommends...
14 KB (1,024 words) - 07:11, 7 September 2024
"Exforge EPAR". European Medicines Agency (EMA). 17 January 2007. Retrieved 26 August 2024. "Copalia EPAR". European Medicines Agency (EMA). 16 January...
6 KB (343 words) - 21:45, 26 August 2024
vaccine has since been approved by several medicine agencies worldwide, such as the European Medicines Agency (EMA), and the Australian Therapeutic Goods...
214 KB (17,080 words) - 15:51, 27 September 2024
European Medicines Agency (EMA) approved aflibercept (Eylea) for the treatment of wet macular degeneration. In February 2013, the European Medicines Agency...
37 KB (2,769 words) - 07:00, 20 November 2024
European Medicines Agency (EMA). 26 January 2023. Archived from the original on 27 January 2023. Retrieved 28 January 2023. "Sohonos EPAR". European Medicines...
19 KB (1,261 words) - 21:45, 21 November 2024
by the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA) was based on data from two randomized, double-blind, placebo-controlled...
24 KB (1,917 words) - 17:27, 12 October 2024
viral infections. The most common side effects reported by the European Medicines Agency (EMA) include injection-site reactions (such as redness, swelling...
23 KB (1,813 words) - 18:30, 5 November 2024